Cargando…
Pharmacological brain cytoprotection in acute ischaemic stroke — renewed hope in the reperfusion era
For over 40 years, attempts to develop treatments that protect neurons and other brain cells against the cellular and biochemical consequences of cerebral ischaemia in acute ischaemic stroke (AIS) have been unsuccessful. However, the advent of intravenous thrombolysis and endovascular thrombectomy h...
Autores principales: | Fisher, Marc, Savitz, Sean I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788909/ https://www.ncbi.nlm.nih.gov/pubmed/35079135 http://dx.doi.org/10.1038/s41582-021-00605-6 |
Ejemplares similares
-
Acute ischaemic stroke: recent advances in reperfusion treatment
por: Widimsky, Petr, et al.
Publicado: (2022) -
Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences
por: Widimsky, Petr, et al.
Publicado: (2014) -
Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design
por: Li, Shuya, et al.
Publicado: (2021) -
Precision management of brain oedema after acute ischaemic stroke
por: Wu, Simiao, et al.
Publicado: (2022) -
Brain Edema After Ischaemic Stroke
por: Dostovic, Zikrija, et al.
Publicado: (2016)